Early-stage funding for European life sciences companies

We are a venture capital firm specialised in seed investment for innovative early stage companies. BGV generally acts as lead investor. Our current portfolio comprises of biotech developing truly disruptive solutions for high unmet medical needs.

Acerta, a multi-billion Euro success story

BioGeneration was co-founder and investor in the most successful biotech startup in Europe: Acerta Pharma. Acerta Pharma has developed Calquence® (acalabrutinib), a drug now approved by the FDA for the treatment of hematologic malignancies (leukemia). Acerta was sold to AstraZeneca for up to US$ 7 billion in 2016.

Shaping new life-science ventures

We gained our experience from working within small and large pharma and biotech companies. Based on this experience and through our extensive industry network, we are able to bring a range of sector-relevant expertise to help accelerate product development and shape the companies to become attractive investment opportunities for the industry.

Latest news

Confo Therapeutics Enters Collaborative Agreement with Regeneron

Confo will work together with Regeneron to apply its GPCR drug discovery platform to enable functional antibody discovery Ghent, Belgium – November 30, 2021 – Confo Therapeutics today announced that it has entered into a collaborative agreement with Regeneron...

Next events

19 – 21 October BioEntrepreneurship Summit 2021

At the BioEntrepreneurship Summit 2021, founders, startup enthusiasts, experienced entrepreneurs, corporates and investors will come together to foster the exchange of knowledge, to inspire and to empower, and to celebrate life science entrepreneurship. In 2021, the...

25-28 October – BioEurope

Building Partnerships in a Digital Age - Facilitating the flow of global life science deals. The international BIO-Europe® 2021 gathering will be held digitally, standing tall in this time of insecurity, to execute on its pivotal role in bringing the global biopharma...

25 November Dutch Life Sciences Conference

The 17th edition of the Dutch Life Sciences conference will take place on November 25th, 2021 and will be about "Breaking Barriers for Our Future." The COVID-19 pandemic has changed the world in many ways. The life sciences sector...

Latest investments

Subscribe to BGV news updates

Join our mailing list to receive the latest news and updates from our team.

Privacy Policy

Please check your email to complete your subscription.